Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0893320040190030287
Journal of Environmental Toxicology
2004 Volume.19 No. 3 p.287 ~ p.294
Development of Animal Model for Diabetes and Hyperlipidemia
Oh Seung-Hyun

Noh Kyoung-Jin
Park In-Sun
Min Bon-Hong
Doo Ho-Kyung
Ahn Se-Young
Kim Yong-Suk
Seong Je-Kyung
Abstract
Diabetic complication is one of major risk factors leading to vascular disease such as atherosclerosis, stroke, coronary heart disease and etc. Several factors affecting the acceleration of diabetic vascular complication have been known such as hypertension, hyperlipidemia, immune complex and genetic factors. To screen and develop new therapeutics agents for diabetic vascular complication, it is strongly needed to develop animal models for diabetic complications. However in rodents models, diabetic complications is not well developed. Furthermore to assess the possibility of new therapeutics for diabetic vascular complications, diabetic animal models which have the risk factors of diabetic complications is needed. We aim to develop and establish an diabetic animal model which have diabetic complications with hyperlipidemia which is one of risk factors for diabetic complications. We induced insulin -dependent diabetes by intra. venous injection of streptozotocin (35 mg/kg/day) in RICO rats which is a spontaneous animal model for hyperlipidemia. Our models (STZ RICO) showed hyperglycemia, persistent high level of plasma cholesterol and triglyceridemia with severe diabetic renal changes until 28 weeks after induction of diabetes. STZ-RICO rats could be used for the evaluations of newly developed diabetic drugs
KEYWORD
diabetes, hyperlipidemia, RICO, animal model
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)